Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: Long-term results of a prospective phase II clinical trial

Rohtesh S. Mehta; Roland Bassett; Amanda Olson; Julianne Chen; Sairah Ahmed; Amin M. Alousi; Paolo Anderlini; Gheath Al-Atrash; Qaiser Bashir; Stefan O. Ciurea; Chitra M. Hosing; Jin S. Im; Partow Kebriaei; Issa Khouri; David Marin; Jeffrey J. Molldrem; Yago Nieto; Betul Oran; Katayoun Rezvani; Muzaffar H. Qazilbash; Samer A. Srour; Elizabeth J. Shpall; Borje S. Andersson; Richard E. Champlin; Uday R. Popat

doi:10.3324/haematol.2018.214429

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: Long-term results of a prospective phase II clinical trial

Rohtesh S. Mehta, Roland Bassett, Amanda Olson, Julianne Chen, Sairah Ahmed, Amin M. Alousi, Paolo Anderlini, Gheath Al-Atrash, Qaiser Bashir, Stefan O. Ciurea, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Jeffrey J. Molldrem, Yago Nieto, Betul Oran, Katayoun Rezvani, Muzaffar H. QazilbashSamer A. Srour, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin, Uday R. Popat

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	E555-E557
Journal	Haematologica
Volume	104
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2018.214429
State	Published - 2019

ASJC Scopus subject areas

Hematology

MD Anderson CCSG core facilities

Biostatistics Resource Group

Access to Document

10.3324/haematol.2018.214429

Cite this

@article{9b0ac6ea4ef04c84af174ac7e1c66cc4,

title = "Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: Long-term results of a prospective phase II clinical trial",

author = "Mehta, {Rohtesh S.} and Roland Bassett and Amanda Olson and Julianne Chen and Sairah Ahmed and Alousi, {Amin M.} and Paolo Anderlini and Gheath Al-Atrash and Qaiser Bashir and Ciurea, {Stefan O.} and Hosing, {Chitra M.} and Im, {Jin S.} and Partow Kebriaei and Issa Khouri and David Marin and Molldrem, {Jeffrey J.} and Yago Nieto and Betul Oran and Katayoun Rezvani and Qazilbash, {Muzaffar H.} and Srour, {Samer A.} and Shpall, {Elizabeth J.} and Andersson, {Borje S.} and Champlin, {Richard E.} and Popat, {Uday R.}",

note = "Funding Information: this work was supported in part by the Cancer Center Support Grant (NCI Grant P30 CA016672). Funding Information: Funding: this work was supported in part by the Cancer Center Support Grant (NCI Grant P30 CA016672). Correspondence: UDAY POPAT [email protected] doi:10.3324/haematol.2018.214429 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2019",

doi = "10.3324/haematol.2018.214429",

language = "English (US)",

volume = "104",

pages = "E555--E557",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

TY - JOUR

T1 - Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia

T2 - Long-term results of a prospective phase II clinical trial

AU - Mehta, Rohtesh S.

AU - Bassett, Roland

AU - Olson, Amanda

AU - Chen, Julianne

AU - Ahmed, Sairah

AU - Alousi, Amin M.

AU - Anderlini, Paolo

AU - Al-Atrash, Gheath

AU - Bashir, Qaiser

AU - Ciurea, Stefan O.

AU - Hosing, Chitra M.

AU - Im, Jin S.

AU - Kebriaei, Partow

AU - Khouri, Issa

AU - Marin, David

AU - Molldrem, Jeffrey J.

AU - Nieto, Yago

AU - Oran, Betul

AU - Rezvani, Katayoun

AU - Qazilbash, Muzaffar H.

AU - Srour, Samer A.

AU - Shpall, Elizabeth J.

AU - Andersson, Borje S.

AU - Champlin, Richard E.

AU - Popat, Uday R.

N1 - Funding Information: this work was supported in part by the Cancer Center Support Grant (NCI Grant P30 CA016672). Funding Information: Funding: this work was supported in part by the Cancer Center Support Grant (NCI Grant P30 CA016672). Correspondence: UDAY POPAT [email protected] doi:10.3324/haematol.2018.214429 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85075959945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075959945&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.214429

DO - 10.3324/haematol.2018.214429

M3 - Letter

C2 - 30948491

AN - SCOPUS:85075959945

SN - 0390-6078

VL - 104

SP - E555-E557

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: Long-term results of a prospective phase II clinical trial

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this